Skip to content
OpenCapital
Get started

CONMED CNMD Financing — other

Financing — other at other companies

Medtronic logo
MedtronicMDT
——
Solventum logo
SolventumSOLV
——
Haemonetics logo
HaemoneticsHAE
——
LivaNova logo
LivaNovaLIVN
——
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
——

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's financing — other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's financing — other?
CONMED (CNMD) reported financing — other of $828K in Q1 2026.
How has CONMED's financing — other changed year-over-year?
CONMED's financing — other increased by 278.4% year-over-year, from -$464K to $828K.
What is the long-term trend for CONMED's financing — other?
Over 3 years (2022 to 2025), CONMED's financing — other has grown at a -72.8% compound annual growth rate (CAGR), from $8.48M to $170K.